Renal Denervation

July 31, 2014 — Radiation therapy may offer a promising new noninvasive alternative treatment for the millions of Americans whose high blood pressure doesn’t respond to medication, suggests preliminary research presented at the 56th annual me...

Patients with hypertension after renal artery stenting who do not respond to drug treatment may have another option. 

SYMPLICITY HTN-3 TRial, ACC.14, renal denervation

A major disappointment earlier this year was the announcement by Medtronic that its renal denervation system failed to meet its primary endpoint for efficacy in the U.S. SYMPLICITY HTN-3 trial. This trial data was presented to a packed, standing-r...

renal denervation

One of the exciting new frontiers for interventional cardiology is the use of renal denervation therapy to treat pharmacologically uncontrolled hypertension. It is estimated there are more than 10 million drug-resistant hypertension patients...

VIVA Physicians, a not-for-profit organization in the field of vascular medicine and intervention, announced late-breaking clinical trial results VIVA 14...
Twelve-month Data St. Jude Medical EnligHTN Renal Denervation System
St. Jude Medical Inc. announced 12-month outcome data from the EnligHTN III study, which demonstrated a continuation of safe, rapid and effective treatment...
September 2, 2014 — Boston Scientific has released the primary endpoint results from its NEural Cardiac TherApy foR Heart Failure (NECTAR-HF) clinical trial,...
September 2, 2014 — Renal denervation reduces recurrent atrial fibrillation (AF) when performed with pulmonary vein isolation ablation in patients with AF and...

Articles

July 31, 2014 — Radiation therapy may offer a promising new noninvasive alternative treatment for the millions of Americans whose high blood pressure doesn’t...
Journal of Endovascular Therapy Hypertension Renal Denervation Therapy
Patients with hypertension after renal artery stenting who do not respond to drug treatment may have another option. 
Medtronic, SYMPLICITY, SYMPLICITY HTN-3 trial, renal denervation, ACC.14
A major disappointment earlier this year was the announcement by Medtronic that its renal denervation system failed to meet its primary endpoint for efficacy...
Medtronic, symplicity, renal denervation
Medtronic Inc. announced its U.S. pivotal trial for its Symplicity renal denervation system to treat resistant hypertension, the SYMPLICITY HTN-3 trial, failed...

Video Center

All major technology advances in the world of radiology, including cardiac imaging, are unveiled or...
2 days 7 hours ago
By Dave Fornell, editor of DAIC Magazine The key take away messages from the 26th annual...
8 weeks 5 days ago
As technology continues to advance for all diagnostic imaging modalities, it sometimes reminds me...
12 weeks 8 hours ago
The CME webinar "State of the Art in MRI Pediatric Brain Perfusion Imaging" will educate participants in the state of the art clinical and emerging...
This webinar discusses why contemporary adult cardiac interventions require significant ionizing radiation with potential health risks to both the patient and...
This webinar explained the benefits of better access, productivity and revenue cycle efficiency in a modern cardiovascular information system (CVIS...

Comparison Charts

Sorry there is no data available